It has been pointed out that in my recent review of chronic inhalation studies with mainstream cigarette smoke in rats and mice (2) I mistakenly did not include a relevant finding. The reason for the omission is that I limited my review to peer-reviewed papers in the scientific literature. One of the papers I reviewed contained data on a smoke-exposed group of female (C57Bl/Cum X C3H/AnfCum)Fl mice and a comparable set of shamexposed controls (4), and I stand by my analysis of the incidences of lung tumors in these groups (statistically, the rates were identical throughout the experiment). As I stated in my paper, a larger set of data on this experiment was presented as a Final Report (3). Upon examination of this larger data set, I found that there were histopathology data on a group of mice, namely a shelf control group, and that these data were not present in the published paper. The paper presents survival and body weight data for 3 groups, but comparative histopathology data are only given for 2 groups (the shelf controls are inexplicably excluded) (4).
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Tables 35-37 of the report present data for incidences of alveolar adenocarcinoma in 3 groups of mice (3) . For shelf control, smoke-exposed, and sham-exposed groups these incidences were 18, 11, and 7 animals, respectively (combining data in columns &dquo;Year 2&dquo; and &dquo;Year 3&dquo; in each of the tables). Table 31 of the report gives the number of cumulative animals diagnosed by histopathology after 3 years; for shelf control, smoke-exposed, and sham-exposed there were 369, 985, and 659 animals, respectively (3) . These data result in lung carcinoma rates of 4.88, 1.12, and 1.06% for shelf control, smoke-exposed, and sham-exposed, respectively.
The shelf-control animals thus have a lung carcinoma rate 4.4 times greater than that of the smoke-exposed an-imals, a finding that is not mentioned in either the paper (4) or the report (3). Stress and/or nutrition could be the reason for these findings, because &dquo;the rate of weight gain of the untreated, shelf control animals were significantly greater (p < 0.05) than that of the smoke and sham exposed mice,&dquo; and &dquo;no difference between the mean body weights of the smoke and sham exposed mice was found over the course of the study&dquo; (3) . I estimate from Figure 2 of the paper (4) that at 96 weeks on test, the shelf control animals were approximately twice as heavy as were the smoke-exposed and the sham-exposed animals. Whatever the reason for the reduced incidence in smoke-exposed and sham controls (or the increased incidence in shelf controls), these new data clearly add to recent concerns over the validity of lifetime mouse cancer tests (1 
